N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents
US4619941A · kind A · utility
12Cited by
1References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1984 |
| Grant date | Oct 28, 1986 |
| Priority date | — |
| Expiry date | Nov 19, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention discloses novel N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides which are useful as inhibitors of thromboxane synthetase and/or as antihypertensive agents in the treatment of hypertension and myocardial ischemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.